Skip to main content
Integrated Proteins Ltd. logo

Integrated Proteins Ltd. — Investor Relations & Filings

Ticker · 519606 ISIN · INE177M01013 BSE.NS Manufacturing
Open in API
Filings indexed 303 across all filing types
Latest filing 2024-12-05 Regulatory Filings
Country IN India
Listing BSE.NS 519606

About Integrated Proteins Ltd.

https://www.integratedproteins.com/

Integrated Proteins Ltd. specializes in the processing and manufacturing of protein-rich products and edible oils. The company operates a solvent extraction plant focused on the production of de-oiled cakes and refined oils, primarily derived from soybeans and other oilseeds. Its core activities include the extraction of high-quality vegetable proteins used extensively in the animal feed industry, particularly for poultry and aquaculture. The company maintains integrated facilities to ensure quality control throughout the production cycle, from raw material sourcing to the final extraction process. By leveraging advanced solvent extraction technology, Integrated Proteins Ltd. produces nutrient-dense soy meal and refined vegetable oils that serve both domestic and international food and feed sectors. The organization emphasizes technical efficiency and product consistency to meet the rigorous standards of the global protein market.

Recent filings

Filing Released Lang Actions
Pursuant to Reg 47 of SEBI(LODR), KFA the copies of Newspaper Advertisement
Regulatory Filings
2024-12-05 English
Intimation of Notice of Postal Ballot Process initiated by the Company.
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice regarding the initiation of a postal ballot process by Integrated Proteins Limited. It includes references to the Companies Act, 2013, and various regulatory circulars, and outlines multiple special resolutions for shareholder approval, such as increasing authorized share capital, issuance of convertible equity warrants, amendments to the Memorandum of Association, and appointments of directors. The document specifies the voting process, cut-off dates, and e-voting instructions. It is not a report of voting results, nor a management or financial report, but rather a formal notice to shareholders to solicit their votes on corporate actions via postal ballot. This fits the definition of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or resolutions.
2024-11-29 English
Disclosure under Regulation 30 of SEBI(LODR), 2015 regarding reconstitution of the Committees of the Board with immediate effect.
Board/Management Information Classification · 95% confidence The document is an official communication from Integrated Proteins Limited to the stock exchange (BSE Limited) regarding the reconstitution of the Board committees, specifically the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 30, which pertains to disclosures about changes in the board or its committees. The document details appointments and committee compositions but does not contain financial data, earnings, or report content. It is an announcement about changes in the company's board committees, fitting the category of Board/Management Information (MANG). The document length is 3338 characters, which is short and consistent with an announcement rather than a full report. Therefore, the correct classification is MANG with high confidence.
2024-11-27 English
KFA the Disclosure under Regulation 30(6) read with Schedule III, Part A, Para A of SEBI Listing Regulations regarding Preferential Allotment.
Capital/Financing Update Classification · 95% confidence The document is a formal announcement addressed to the stock exchange (BSE Limited) regarding the approval and details of a preferential allotment of convertible equity warrants by Integrated Proteins Limited. It references compliance with SEBI Listing Regulations and ICDR Regulations, specifies the number of warrants, pricing, allottee details, and post-allotment shareholding changes. The document is not a financial report but a regulatory announcement about a capital raising event through preferential allotment. It does not contain financial statements or earnings data but focuses on issuance and allotment of securities. Therefore, it fits the category of Capital/Financing Update (CAP). The document length (9605 characters) and detailed disclosure support this classification with high confidence.
2024-11-27 English
With reference to above subject and in compliance with Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Integrated Proteins Limited addressed to the stock exchange (BSE Limited) regarding the outcome of a Board of Directors meeting held on November 27, 2024. It details several corporate actions approved by the board, including the issuance and allotment of convertible equity warrants on a preferential basis, increase in authorized share capital, amendment of the Memorandum of Association, shifting of registered office, approval of postal ballot notice, appointment of scrutinizer, and reconstitution of board committees. The document references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30 and 33, which pertain to disclosure of material events and financial results. The content is focused on corporate governance and capital structure changes rather than financial results or detailed financial statements. It includes detailed disclosures about the preferential issue and committee reconstitution, which are typical of regulatory announcements about board decisions and corporate actions. The document is not a full financial report, earnings release, or audit report, nor is it a proxy or voting result announcement. It is a regulatory filing announcing the outcome of a board meeting and related corporate actions as required by stock exchange regulations.
2024-11-27 English
INTEGRATED PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/11/2024 ,inter alia, to consider and approve Dear Sir/Madam, Pursuant ....
Board/Management Information Classification · 95% confidence The document is a formal communication from Integrated Proteins Limited to the stock exchange (BSE Limited) regarding the scheduling and postponement of a Board Meeting. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about board meetings. The content includes details about the agenda items to be discussed in the upcoming board meeting, such as capital raising proposals, changes in authorized share capital, change of company name, alteration of company objects, shifting registered office, and approval of postal ballot notice draft. There is no financial data, earnings information, or detailed report content. Instead, it is an announcement about the board meeting and its agenda, which fits the category of Board/Management Information (MANG). The document length is 5462 characters, which is sufficient for a detailed announcement but does not contain financial statements or report data. Therefore, the appropriate classification is MANG with high confidence.
2024-11-23 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.